Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 04-2024 | 01-2024 | 10-2023 | 07-2023 | 04-2023 | |
| Sales | 3 | 0 | 0 | 3 | 8 |
| Cost of Goods | 1 | 0 | 0 | 0 | 8 |
| Gross Profit | 2 | 0 | 0 | 2 | 0 |
| Operating Expenses | 50 | 47 | 270 | 166 | 220 |
| Operating Income | -48 | -47 | -270 | -164 | -220 |
| Interest Expense | 29 | 24 | 27 | 10 | 9 |
| Other Income | -9 | 12 | -3,474 | 10 | -6 |
| Pre-tax Income | -86 | -59 | -3,770 | -164 | -234 |
| Net Income Continuous | -86 | -59 | -3,770 | -164 | -234 |
| Net Income | $-86 | $-59 | $-3,770 | $-164 | $-234 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.06 | 0.00 | 0.00 |
| EBITDA(a) | $-57 | $-35 | $-3,608 | $-18 | $-88 |